VP9-24556-21213
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Registered in v-safe
- 2020-12-30
- 2021-01-02
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-15
- 2021-01-20
- 2021-01-27
- 2021-02-03
-
2021-02-10
Survey response — day 35, dose 2MedDRA: Cough, Upper-airway cough syndrome — Feeling: FairFree text: Post nasal drip with slight coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
-
2021-04-07
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous — Feeling: GoodFree text: MiscarriageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech |
Free text
Release 4 — day 35, dose 2
Symptoms: Post nasal drip with slight cough
Release 7 — 3 months, dose 2
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release